Real-time enrollment status for this retinitis pigmentosa clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 9:24 AM UTC
| NCT Number | NCT06912633 |
| Recruiting Status | Recruiting |
| Condition | Retinitis Pigmentosa |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 14 sites in the US |
| Sponsor | jCyte, Inc |
| Last Updated on CT.gov | April 13, 2026 (Apr 13, 2026) |
As of July 18, 2026: Clinical trial NCT06912633 is currently recruiting participants. This phase2 study for retinitis pigmentosa is actively seeking new participants at 14 locations across the United States. The study is sponsored by jCyte, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06912633 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06912633 was last updated Apr 13, 2026 (April 13, 2026). HelloStudys verifies this status automatically.